Protagonist Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Protagonist Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 126% to $60,000,000. The net income raised on -$78,955,000 and profit margin reached -132%. Total operating expenses were $153,652,000.
Profit Margin
| 2014 | 0 | -11.07M | |
|---|---|---|---|
| 2015 | 0 | -14.85M | |
| 2016 | 0 | -37.17M | |
| 2017 | 20.06M | -36.95M | -184.2% |
| 2018 | 30.92M | -38.92M | -125.87% |
| 2019 | 231K | -77.18M | -33414.29% |
| 2020 | 28.62M | -66.15M | -231.07% |
| 2021 | 27.35M | -122.62M | -448.25% |
| 2022 | 26.58M | -123.41M | -464.29% |
| 2023 | 60M | -78.95M | -131.59% |
PTGX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 60M | 26.58M | 27.35M | 28.62M | 231K | 30.92M | 20.06M | 0 | 0 | 0 |
Cost of revenue | 0 | 1.03M | 2.77M | 0 | 0 | 0 | 0 | 0 | 247K | 0 |
Gross profit | 60M | 25.54M | 24.58M | 28.62M | 231K | 30.92M | 20.06M | 0 | -247K | 0 |
Operating exp. | ||||||||||
Research and development | 120.16M | 126.21M | 126.00M | 74.50M | 65.00M | 59.49M | 46.18M | 25.70M | 11.83M | 7.45M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 153.65M | 157.95M | 153.20M | 93.14M | 80.75M | 73.19M | 57.96M | 32.66M | 14.79M | 9.31M |
Operating income | -93.65M | -131.37M | -125.84M | -64.51M | -80.52M | -42.26M | -37.89M | -32.66M | -14.79M | -9.31M |
Other income (expenses), net | 14.69M | 3.98M | 294K | -329K | 2.64M | 2.54M | 940K | -4.75M | -64K | -1.75M |
Income before tax | -78.95M | -127.39M | -125.55M | -64.84M | -77.87M | -39.72M | -36.95M | -37.17M | -14.85M | -11.07M |
Income tax expense | 0 | -3.98M | -2.92M | 1.30M | -691K | -799K | -406K | 4.16M | 64K | 1.75M |
Net income | -78.95M | -123.41M | -122.62M | -66.15M | -77.18M | -38.92M | -36.95M | -37.17M | -14.85M | -11.07M |
Earnings per share | ||||||||||
Basic EPS | -1.39 | -2.52 | -2.65 | -1.92 | -2.98 | -1.74 | -2.09 | -5.72 | -2.52 | -1.88 |
Diluted EPS | -1.39 | -2.52 | -2.65 | -1.92 | -2.98 | -1.74 | -2.09 | -5.72 | -2.52 | -1.88 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |